Press Releases

Date	Title	Company
30-Mar-2021	Vita 34 continues to grow in 2020 in core markets after good year-end business	Vita 34 AG
30-Mar-2021	Dermapharm posts growth despite COVID-19 pandemic - consolidated revenue and EBITDA continue to rise	Dermapharm Holding SE
30-Mar-2021	Relief Confirms Release of 60-Day Findings from Phase 2b/3 Clinical Trial of Intravenous RLF-100(TM) (aviptadil)	RELIEF THERAPEUTICS Holdings AG
29-Mar-2021	Novel Phenomics NASH In Vitro Assay Presented by InSphero AG and PharmaNest Inc at 2021 Society of Toxicology Meeting	Newswire
29-Mar-2021	gaitQ Awarded Grant by the UK’s National Institute for Health Research for the continued development of its system	gaitQ
29-Mar-2021	EMA issues advice on the use of Celltrion’s anti-COVID-19 monoclonal antibody treatment regdanvimab (CT-P59) for COVID-19 patients in the European Union	Celltrion Group
29-Mar-2021	Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations	Autolus Therapeutics plc
29-Mar-2021	The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health Prioritization from the UK government	UNION therapeutics A/S
29-Mar-2021	HUTCHMED Initiates International Phase I Trials of IDH1/2 Dual Inhibitor in Patients with Advanced Solid Tumors or Hematological Malignancies	HUTCHMED
29-Mar-2021	OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer	OKYO Pharma Limited
29-Mar-2021	Instant Covid Tests London to launch first test centre using 20-second Virolens technology	Instant Covid Tests London (ICTL)
29-Mar-2021	Syncona cornerstones $148 million Series C Financing in Gyroscope	Syncona Ltd
29-Mar-2021	Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation	Vertex Pharmaceuticals Incorporated
29-Mar-2021	Gadopiclenol: positive results for Phase III clinical trials	Guerbet
29-Mar-2021	Avifavir obtains its first registration in Asia	Russian Direct Investment Fund
29-Mar-2021	PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKey	PrecisionLife
29-Mar-2021	HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors	Hutchison China MediTech Limited
29-Mar-2021	Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery	University of Birmingham
29-Mar-2021	LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology	Nordic Capital
29-Mar-2021	Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials	Amzell BV